Dementia pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
* Chronic, progressive neurodegenerative disorder characterized by a global, nonreversible impairment in cerebral functioning. | |||
* Deteriorating course over up to 8-10 years. | |||
* Brain lesions are marked by neurofibrillary tangles, senile plaques, neuronal loss, and brain atrophy, with defects in acetylcholine synthesis at the cellular level. | |||
==Pathophysiology== | ==Pathophysiology== | ||
Line 17: | Line 22: | ||
These changes are usually present in the hippocampus, amygdala, cortex, and nucleus basalis | These changes are usually present in the hippocampus, amygdala, cortex, and nucleus basalis | ||
== Genes == | ==Genes== | ||
<br />Genes involved in the pathogenesis of dementia include | <br />Genes involved in the pathogenesis of dementia include | ||
* Amyloid precursor protein (''APP)'' | *Amyloid precursor protein (''APP)'' | ||
* Presenilin 1 (''PSEN1)'' | *Presenilin 1 (''PSEN1)'' | ||
* Presenilin 2 (''PSEN2)'' | *Presenilin 2 (''PSEN2)'' | ||
* Apolipoprotein E (''APOE)'' | *Apolipoprotein E (''APOE)'' | ||
* ''C9ORF72'' | *''C9ORF72'' | ||
* | *''MAPT'' | ||
* ''GRN'' | *''GRN'' | ||
__NOTOC__ | __NOTOC__ | ||
{{Template:Dementia}} | {{Template:Dementia}} |
Revision as of 02:51, 3 October 2020
Dementia Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: ,Sabeeh Islam, MBBS[2]
Overview
- Chronic, progressive neurodegenerative disorder characterized by a global, nonreversible impairment in cerebral functioning.
- Deteriorating course over up to 8-10 years.
- Brain lesions are marked by neurofibrillary tangles, senile plaques, neuronal loss, and brain atrophy, with defects in acetylcholine synthesis at the cellular level.
Pathophysiology
While the pathogenesis of AD remains unclear, It is thought that dementia is the result of
- Overproduction and/or decreased clearance of amyloid beta peptides
- Accumulation of tau proteins
- Accumulation of neurofibrillary tangles
- Production of oxygen radicals and nitric oxide, and inflammatory processes
- Decreased levels of cholinergic neurotransmission.
- Over-excitation of the glutamate neurotransmitter system via N-methyl-D-aspartate receptors
These changes are usually present in the hippocampus, amygdala, cortex, and nucleus basalis
Genes
Genes involved in the pathogenesis of dementia include
- Amyloid precursor protein (APP)
- Presenilin 1 (PSEN1)
- Presenilin 2 (PSEN2)
- Apolipoprotein E (APOE)
- C9ORF72
- MAPT
- GRN
Dementia Microchapters |